A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes
NCT07591168
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
92
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndromes
Interventions
DRUG:
BL-M11D1
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators
[object Object]